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Severe immunosuppression is a hallmark of Morbillivirus infections. To study the underlying mechanisms, we have developed a ferret model
of canine distemper virus infection. The model reproduces all clinical signs of measles, but the lack of ferret-specific reagents has limited the
characterization of the cellular immune response. Towards this, we cloned ferret cytokines and established semi-quantitative real-time PCR assays.
To demonstrate the utility of these assays we compared the cytokine profiles elicited by lethal and non-lethal strains during the prodromal phase.
We observed a general lack of cytokine induction in animals that later succumbed to the disease, whereas survivors mounted a robust and
sustained response. The newly developed cytokine assays strengthen and expand the ferret model not only for Morbillivirus pathogenesis studies
but also for several other human respiratory viruses including influenza and SARS.
© 2007 Elsevier Inc. All rights reserved.Keywords: Morbillivirus; Canine distemper virus; Immunosuppression; Ferret cytokine mRNA quantification; Prediction of disease outcomeIntroduction
Morbilliviruses are highly contagious respiratory pathogens
that cause systemic disease and are accompanied by severe
immunosuppression (Griffin, 2001; Murphy et al., 1999).
Disease severity varies from moderate to severe for measles
(MV) in humans and canine distemper virus (CDV) in dogs to
usually lethal for CDV in most wild carnivores and rinderpest in
cattle (Rima and Duprex, 2006). Regardless of the ultimate
disease outcome, the infection is characterized by a dramatic
decrease of white blood cells and an inhibition of lymphocyte
proliferation within the first weeks after infection (Borrow and
Oldstone, 1995; Griffin, 2001; von Messling et al., 2003).
However, the knowledge regarding interactions between the
host and the immune system preceding these events remains
limited.
Since MV only infects humans and certain non-human
primates, we have established a model based on the study of the
closely related canine distemper virus (CDV) in ferrets, one of⁎ Corresponding author. Fax: +1 450 686 5305.
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doi:10.1016/j.virol.2007.01.002its natural hosts (von Messling et al., 2003). Ferrets are highly
sensitive to the disease, and for the most part succumb to
infection with a wild type virus. On the other hand, infection
with attenuated CDV strains results in disease signs and
progression that parallels MV infection in humans (Kauffman et
al., 1982). Virus control and clearance in surviving animals
usually occur within 3 to 4 weeks after inoculation and coincide
with the development of neutralizing antibodies (von Messling
et al., 2004, 2003). The application of our model to study the
immune response during the crucial early phase of CDV
infection has so far been difficult as specific reagents to detect
cytokine responses in ferrets are not readily available.
This lack of immunological reagents constitutes a major
limitation for the use of ferrets in pathogen–host interaction
studies, for which it is becoming increasingly attractive. Ferrets
are naturally susceptible to several human respiratory pathogens
and a number of gastro-intestinal bacterial diseases (Ball, 2006).
They have long been recognized as a model for the efficacy
assessment of new vaccines or treatment approaches against
influenza and more recently severe acute respiratory syndrome
(SARS), and they are also used to study prion diseases (Bartz et
al., 1998; Maher and DeStefano, 2004; Ter Meulen et al., 2006).
Table 1
Comparison of ferret cytokines with the respective canine and feline protein
sequences available in GenBank
Protein % AA identity % AA identity
Ferret/Dog Ferret/Cat
IFNα a 67 72
IFNγ b 88 85
TNFα 95 92
IL2 86 85
IL4 83 77
IL6 78 73
IL10 b 93 89
IL12p40b 94 92
a Values based on consensus sequence.
b Values based on alignment of available gene sequence.
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based cytokine assays for ferrets and to validate this new tool by
comparing the early host response to lethal and non-lethal CDV
infections. Towards this, we completed the sequences of ferret
cytokines representing the different axes of the cellular immune
response and developed semi-quantitative real-time PCR
assays. We then evaluated cytokine mRNA expression levels
at 3 and 7 days after inoculation and found that survival was
associated with a robust and sustained response whereas
animals that succumbed to the disease experienced a general-
ized shutoff of cytokine expression.
Results
Cloning and characterization of ferret cytokines
Since reagents for the assessment of the cellular immune
response in ferrets are not commercially available, we set out to
obtain the sequences of a ferret cytokine panel including those
reflecting early innate immune response activation, tumor
necrosis factor (TNF) α, interferon (IFN) α, and interleukin
(IL) 6, those indicating Th1 polarization, IFNγ, IL2, and
IL12p40, and the Th2 cytokines IL4 and IL10. As mustelids,
ferrets are most closely related to other carnivores like dogs and
cats (McKenna and Bell, 1997). The first set of primers was
therefore based on canine and feline sequences available in
GenBank. We initially obtained small fragments of ferret IFNα,
IFNγ, IL2, IL4, IL6, and TNFα and used those sequences to
measure cytokine mRNA induction using a gel-based assay (von
Messling et al., 2006). To develop a robust and versatile real-
time PCR-based assay that generates a representative cytokine
profile, we included IL10 and IL12p40 and pursued the
sequencing of larger parts of the open reading frames. This
strategy has so far yielded complete open reading frames for IL2,
IL4, IL6, IFNα (consensus sequence), and TNFα (GenBank
accession nos. IL2 EF368206; IL4 EF368210; IL6 EF368209;
IFNα EF368207; TNFα EF368211) and partial gene sequences
for IL10 and IFNγ (>95) and IL12p40 (∼60%; GenBank
accession nos. IL10 EF368212; IFNγ EF368214; IL12p40
EF368213). When comparing the ferret cytokines with the
respective canine and feline proteins, we observed a slightly
higher overall amino acid identity between ferrets and dogs than
between ferrets and cats (Table 1). This degree of similarity on
the amino acid and nucleotide level (data not shown) confirms
the identity of the obtained sequences.
Early CDV immunosuppression is independent of the viral load
To establish and validate ferret cytokine real-time PCR
assays, we compared samples from animals that succumbed to
the disease with those originating from survivors. Different
viruses were included to assure the identification of general
characteristics of disease outcome rather than profiles associated
with one individual strain. Samples included in the lethal group
originated from animals infected with either 5804P-eGFP/H
(von Messling et al., 2004) or A75eH (Rudd et al., 2006),
whereas the survivor group consisted of individuals inoculatedwith the highly pathogenic but non-lethal strain 5804P-eGFP/uN
(von Messling et al., 2004) or survivors of 5804P/A75eH
chimeric viruses. These viruses, in which the envelope
glycoproteins were exchanged between the two lethal strains,
cause severe disease but only 60–80% mortality (unpublished
results). In the case of 5804P-eGFP/uN, which carries an eGFP-
containing additional transcription unit upstream of the N gene,
the non-lethal phenotype is due to a slight delay in replication
efficacy, whereas minimal incompatibilities between viral
proteins originating from different strains are the likely cause
of survival in the case of the 5804P/A75 chimeric viruses.
In animals that succumb to the disease, we observed a
dramatic drop in leukocyte numbers and an almost complete
loss of peripheral blood mononuclear cell (PBMC) proliferation
activity upon phytohemagglutinin (PHA) stimulation between 3
and 7 days after inoculation, prior to the onset of disease signs
(Figs. 1A and B, circles). In contrast, survivors experienced an
equally severe but transient leukocyte drop, and the inhibition of
lymphocyte proliferation was less pronounced (Figs. 1A and B,
triangles). No marked differences in peripheral blood mono-
nuclear cell (PBMC)-associated virus titers and neutralizing
antibody levels against CDV were noted between the two
groups at these early time points (Figs. 1C and D).
Blood cell composition and infection levels at early disease
stages are independent of disease outcome
Because of their important role in CDV pathogenesis and
easy accessibility, PBMCs are ideally suited to follow the
systemic cytokine response over time in the same animal. We
have previously shown that 5804P targets primarily T and B
cells and that a lethal infection results in a relative reduction of
the Tcell population, beginning at 10 days post-infection (d.p.i.)
(von Messling et al., 2006). To assure the comparability
between samples from both groups, we determined infection
levels and PBMC subpopulation composition at the different
time points. Consistent with our previous results, we observed
no infected cells or relevant changes in PBMC subpopulations
at 3 d.p.i. (Figs. 2A and B, compare 0 and 3 d.p.i.). At 7 d.p.i.,
more than 40% of cells expressed eGFP (Fig. 2A, 7 d.p.i.),
which could be further subdivided in 28–30% T cells, 13–21%
Fig. 1. Clinical parameters in animals infected with lethal or non-lethal CDV strains. (A) Leukocyte numbers, (B) in vitro proliferation activity of lymphocytes, (C)
cell-associated virus titers expressed in 50% log10 tissue culture infectious doses (TCID50) in PBMCs, and (D) neutralizing antibody titers over the first 21 days of the
disease. Animals infected with the lethal strains 5804P-eGFP/H (n=5) or A75eH (n=6) are represented by circles, those infected with the non-lethal virus 5804P-
eGFP/uN (n=4) and the survivors of infections with chimeric 5804P/A75eH envelope exchange viruses (n=4) by triangles. Days post-infection are indicated on the X
axis, leukocyte number, proliferation activity, cell-associated virus titer, or neutralizing antibody titer on the Y axis. Error bars represent the standard deviation. The
narrow dotted lines indicate cut-off values associated with moderate (upper line) and severe (lower line) immunosuppression. The wider dotted line represents the
protective threshold of neutralizing antibodies.
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(Fig. 2B, left and right panel). After the onset of clinical signs at
10 d.p.i., the two groups diverged similar to what was observed
in the immunological parameters (Fig. 1).
CDV survival is associated with a robust cytokine response
To determine if the newly established cytokine assays allow
a discrimination of the two groups at early disease stages, when
other assays fail to detect a difference, we compared the relative
induction of the different cytokine mRNAs at 3 and 7 d.p.i. inFig. 2. Extent and PBMC subtype specificity of lethal and non-lethal CDV infection. (
animals that succumbed (black bars) to or survived (white bars) the disease at 0 to 14
percentages of PBMC subtypes infected 0 to 14 days after infection with lethal or
monocyte-lineage cells are shown in blue. Lighter shades represent eGFP-expressin
animals assigned to the respective groups are shown.animals that succumbed to the disease with survivors. The most
striking finding was a generalized lack of cytokine upregulation
in animals infected with a lethal strain at both time points (Figs.
3A–C, circles). For TNFα, IL6, and IL2, we even observed a
reduction in cytokine mRNA levels below baseline in the
majority of animals analyzed, suggesting an infection-induced
shutdown of gene expression (Figs. 3A and B, circles). The only
exception was IL12p40, which was upregulated in a small
subset of the animals examined (Fig. 3B, middle panel, circles).
In contrast, the majority of animals infected with non-lethal
viruses showed a robust upregulation of the innate immuneA) FACS analysis of the percentage of eGFP expression in PBMCs isolated from
days after inoculation. Error bars represent the standard deviation. (B) Relative
non-lethal viruses. T cells are shown in red, B cells are shown in green, and
g cells; full shades represent negative cells. The means of the results from all
Fig. 3. Comparison of cytokine responses in animals infected with lethal or non-lethal CDV strains. (A) Innate immunity, (B) Th1-type, and (C) Th2-type cytokine
mRNA expression in both groups at 3 (D3) and 7 (D7) days post-infection. Animals infected with lethal strains (n=11) are represented by circles, those infected with
non-lethal viruses (survivors; n=8) by triangles. The fold mRNA expression change compared to pre-infection levels of the same animal is indicated on the Y axis.
Each samples was analyzed in triplicates and only samples where the variation among triplicates was less than 10% were included in the analysis, resulting in the
variability in numbers of individuals plotted for the different cytokines. The black bar represents the mean of all the samples. The hatched zone represents threshold
levels of 1.5 fold expression change, which is considered normal variability.
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3 d.p.i., which was sustained through day seven (Figs. 3A and
B, triangles). At the earlier time point, a broad range of IFNα
expression levels was observed, and a subset of animals
displayed a very strong IL10 response (Figs. 3A and C, D3,
triangles). Seven days after inoculation, the Th1-type cytokines
IL2 and IL12p40 and the Th2-type cytokines IL4 and IL10 were
also strongly expressed (Figs. 3B and C, D7, triangles).
Discussion
The dramatic drop in leukocyte numbers and the loss of
function in the remaining cells observed within the first week
after infection indicate that Morbilliviruses interfere with the
induction of an appropriate immune response at very early
stages (Borrow and Oldstone, 1995; Schneider-Schaulies et al.,
2001). To better understand the basis for host immune response
control in our ferret model, we established semi-quantitative
real-time RT-PCR assays based on ferret cytokine sequences
and compared the response associated with lethal diseaseoutcome or survival. We found that animals succumbing to the
disease failed to mount a sustained response, while survivors
showed initially a Th1 polarization that later transitioned into a
Th2-biased response.
Cytokine responses to CDV have so far been mostly studied
in dogs with naturally contracted disease at the time of
euthanasia. The results represent thus the profile at the late
stages of the acute disease phase or at the onset of neurologic
disease after recovery from the acute infection. Interestingly,
animals with severe signs of disease and viremia at the time of
death displayed low or absent cytokine mRNA induction in
blood-derived RNA, consistent with our initial findings in
5804P-infected ferrets and this study (Grone et al., 1998; von
Messling et al., 2006). In contrast, individuals with mild or
absent general signs of disease but neurologic manifestations
mounted a broad response not only in the blood but also locally
in the CNS (Grone et al., 1998; Markus et al., 2002). The role of
the systemic and local immune response in the context of this
delayed neurologic form of CDV remains to be investigated in
ferrets.
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with a lethal virus as early as 3 d.p.i. indicates a viral interference
with immune system activation at a time when the infection in
PBMCs is barely detectable. In vitro, it has been demonstrated
that minute amounts of MV envelope are suffice to induce an
anergic state in exposed lymphocytes, but the exact interactions
remain to be elucidated (Schlender et al., 1996). In addition, the
non-essential protein V has been shown to inhibit activation of
an anti-viral response by interfering with nuclear localization of
STATs (Devaux et al., in press; Palosaari et al., 2003). It is
possible that the shutdown of cytokine expression observed for
the lethal CDV strains results from contacts between viral
glycoproteins and immune cells in combination with a V and
phosphoprotein-dependent inhibition of the induction of the
anti-viral state in infected cells. Taken together our findings
demonstrate that the disease outcome is decided within the first
days of infection.
The Th1/Th2 switch observed in animals infected with non-
lethal viruses mirrors previous reports of children naturally
infected with MV, where IL2 and IFNγ were expressed during
the acute phase of the disease, and the increase of IL4
coincided with antibody-mediated virus clearance (Griffin et
al., 1994; Moss et al., 2002). In the same context, elevated IL10
levels were detected for weeks after the infection, which might
be an important factor in the long-lasting immunosuppression
associated with MV (Moss et al., 2002). In our study, ferrets
infected with non-lethal viruses closely reproduce these
findings, further supporting the value of this model for the
characterization of the mechanisms underlying Morbillivirus-
induced immunosuppression.
In addition to Morbillivirus pathogenesis studies, ferrets are
a recognized model for the development of vaccines and anti-
viral therapies against influenza, and more recently SARS
(Maher and DeStefano, 2004; Ter Meulen et al., 2006). They
are also used for transmission studies of different transmissible
spongiforme encephalopathies (Bartz et al., 1998, 1994) and
parallel human disease manifestations for several bacterial
diseases including Helicobacter-induced gastric ulcers, hemo-
lytic uremic syndrome caused by Shiga toxin-producing
Escherichia coli, and campylobacteriosis (O'Rourke and Lee,
2003; Woods et al., 2002). By comparing samples from
animals with different disease outcome, we have demonstrated
that our semi-quantitative real-time PCR assays are sufficientlyTable 2
Primer pairs used in the cytokine real-time PCR assays
Gene Primers
Forward
IFNα 5′-ATGCTCCTGCGACAAATGAGGAGA-3′
IFNγ 5′-CCATCAAGGAAGACATGCTTGTCAGG-
TNFα 5′-TGGAGCTGACAGACAACCAGCTAA-3′
IL2 5′-TGCTGCTGGACTTACAGTTGCTCT-3′
IL4 5′-CGTTGAACATCCTCACAGCGAGAAAC-
IL6 5′-CAAATGTGAAGACAGCAAGGAGGCA-3
IL10 5′-TCCTTGCTGGAGGACTTTAAGGGT-3′
IL12p40 5′-ATCGAGGTTGTGGTGGGTGCTATT-3′
GAPDH 5′-AACATCATCCCTGCTTCCACTGGT-3′sensitive to detect a very weak response and even a reduction
from baseline levels as observed in animals that later
succumbed to the disease. At the same time, the assays allow
the quantification of the response across a much wider range
than the previous gel-based approach (von Messling et al.,
2006). This will enable the more detailed comparison of the
cytokine responses to specifically attenuated viruses in future
studies. Furthermore, this RNA-based assay can easily be
applied to various tissues as well as bodily fluids, enabling the
assessment of the local and systemic responses at the same
time. It thus adds a versatile new tool to the study of host–
pathogen interactions in this model.
Materials and methods
Ferret cytokine sequences
To obtain sequences encoding ferret IL2, 4, 6, 10, and 12p40,
IFNα and γ, and TNFα, as well as GAPDH as a housekeeping
gene, total RNAwas isolated (RNeasy, Qiagen) from PBMCs of
healthy animals stimulated with 5 μg/ml PHA (Sigma) for 24 h.
The RNA was then reverse transcribed (Superscript III,
Invitrogen) using a mixture of oligoT and random hexamer
primers to maximize cDNA output. Primer pairs for the initial
amplification of ferret cytokines were based on conserved
regions in the respective genes of the phylogenetically related
carnivores, dogs and cats, available in GenBank (canine
sequences: IL2 AM238655; IL4 NM001003159; IL6
NM001003301; IL10 NM001003077; IL12p40 U49100;
IFNα A33693; IFNγ NM001003174; TNFα Z70046; feline
sequences: IL2 NM001043337; IL4 NM001043339; IL6
NM001009211; IL10 NM001009209; IL12p40 Y07762;
IFNα DQ220469; IFNγ X86974; TNFα NM001009835).
Once a partial ferret sequence was determined (von Messling
et al., 2006), ferret specific primers were chosen to obtain
increasing parts of the open reading frame either in combination
additional canine/feline-based primers or by 3′ and 5′ RACE
according to the manufacturer's instruction (GeneRacer RACE-
Ready cDNA kit, Invitrogen). Primer pairs for the real-time
PCR assay were designed using the Primer Quest program of
Integrated DNATechnologies (Table 2). Protein alignments and
the calculation of percent amino acid identity were performed
using MegAlign (DNASTAR, Lasergene).Reverse
5′-TTCTGCAGCTGCTTGCTGTCAAAC-3′
3′ 5′-CTGGACCTGCAGATCATTCACAGGAA-3′
5′-TGATGGTGTGGGTAAGGAGCACAT-3′
5′-CAATTCTGTGGCCTTCTTGGGCAT-3′
3′ 5′-TTGCCATGTTCCTGAGGTTCCTGTGA-3′
′ 5′-TCTGAAACTCCTGAAGACCGGTAGTG-3′
5′-TCCACCGCCTTGCTCTTATTCTCA-3′
5′-TAGGTTCATGGGTGGGTCTGGTTT-3′
5′-TGTTGAAGTCGCAGGAGACAACCT-3′
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The samples analyzed in this study originated from animals
infected with either one of the lethal strains 5804P-eGFP/H (von
Messling et al., 2004) and A75eH (Rudd et al., 2006), the non-
lethal strain 5804P-eGFP/uN (von Messling et al., 2004), and
survivors of infections with chimeric 5804P/A75eH envelope
exchange viruses that cause 60–80% lethality (unpublished
results).
Male ferrets over 16 weeks of age (Marshall Farms) were
inoculated intranasally with 105 50% tissue culture infectious
doses of the respective virus, and blood samples were collected
twice during the first 2 weeks, and weekly thereafter. At each
time point, the total white blood cell count, proliferation
activity, cell-associated virus titers, and neutralizing antibody
titers were determined as described previously (Rudd et al.,
2006; von Messling et al., 2003). Flow cytometry analysis of
the PBMC subpopulations was carried our following the
protocol published previously (vonMessling et al., 2004, 2006).
For the cytokine mRNA quantification, 3 ml blood was
collected in Na–EDTA-coated vacuum tubes (Vacutainer,
Beckton Dickinson) immediately before and at 3 and 7 d.p.i.
PBMCs were isolated by destroying the erythrocytes with ACK
lysis buffer (150 mM NH4Cl, 10 mMKHCO3, 0.01 mM EDTA,
pH 7.2–7.4), resuspended in RNAlater (Qiagen), and stored at
−20 °C. The RNA was purified using the RNeasy kit in
combination with an on-the-column DNase treatment (Qiagen),
and the yield was quantified by UV spectrophotometry.
Semi-quantitative real-time PCR assays
To assess cytokine expression, the cDNA produced from
10 ng RNAwas combined with 0. 5 μM of each primer and the
DyNAmo SYBR Green 2-Step qRT-PCR reaction mix
(Finnzymes) to a 10 μl reaction according to the manufacturer's
instructions. The real-time PCR was performed in a RG-3000A
(Rotor-Gene), using the following protocol: denaturation at
95 °C for 15 min followed by 40 cycles of 95 °C for 5 s, 60 °C
for 15 s, and 72 °C for 25 s, and a melting curve analysis to
confirm reaction specificity. Each experiment was performed in
triplicate, and only values that varied less than 10% were
considered. The fold change ratios between experimental and
control samples for each gene were calculated with GAPDH
levels as a reference. Towards this the cycle at which GAPDH
crosses the detection threshold (Ct) is subtracted from the Ct
value of the gene of interest at each time point (ΔCt). The fold
change is then calculated by subtracting the ΔCt values of the
respective gene at day 0 from those obtained at subsequent days
(ΔΔCt). To transform these values into absolute values, the
formula: fold change=2−ΔΔCt is used (Schmittgen et al., 2000).
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